For example, in line with how PPARγ has been implicated in the pathophysiology of obesity and type 2 diabetes [67,68,70,71], mutations in the gene encoding PPARγ may impact the severity or susceptibility of OKD and CKD in general [69,72]. This evidence concerns the gene PPARG and Obesity.